Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;11(9):e638-e640.
doi: 10.1016/S2352-3026(24)00223-0. Epub 2024 Aug 5.

Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List

Glenn F Pierce  1 , Brian O'Mahony  2 , Radoslaw Kaczmarek  3 , Mark W Skinner  4 , Mike Makris  5 , Flora Peyvandi  6 , Alok Srivastava  7 , Cedric Hermans  8 ; World Federation of Hemophilia Coagulation Products Supply, Safety, and Access Committee (CPSSAC)
Collaborators, Affiliations

Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines List

Glenn F Pierce et al. Lancet Haematol. 2024 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

GP is a consultant for Novo Nordisk, Roche, and Sanofi. BO'M has received honoraria or speaking fees from Biomarin, Bayer, and CSL Behring. RK has served on scientific advisory boards for BioMarin and Pfizer and has received research funding from Bayer. MWS’ institution received research support as part of an independent investigator-initiated research project and received research support, honoraria, or fees from Band Therapeutics, Bayer, Biomarin, CSL, Novo Nordisk, Roche/Genentech, Pfizer, Sanofi, Takeda, and Vega Therapeutics. MM received honoraria from Novo Nordisk, Takeda, Sanofi, and Grifols. FP has received honoraria from Takeda and Spark and has served on advisory boards for CSL Behring, BioMarin, Roche, Sanofi, and Sobi. AS has received research grants from Roche, Novo Nordisk, Sanofi, and Pfizer; has had speaker assignments from Sanofi, Novo Nordisk, Roche, Takeda, Pfizer, Sanofi, BioMarin, and Spark; and is on the advisory boards of Sanofi, Novo Nordisk, Roche, Takeda, Pfizer, BioMarin, and Spark.

Substances

LinkOut - more resources